The meetings will focus on physician-led, patient-centered ACOs and exceed the theoretical by bringing together actual case studies offered by the medical group leaders with initial hand experience in providing accountable treatment to their sufferers. Related StoriesCancer diagnosis improvements in England: an interview with Lucy Elliss-BrookesDiabetic retinopathy therapy improvements: an interview with Richard Kirk, CEO of PolyphotonixSurgical startup seeks funding to build virtual reality schooling libraryAMGA’s meetings will feature innovators from the membership presenting their case research and can culminate in the fall at AMGA’s Institute for Quality Leadership, subtitled the AMGA National Summit on ACOs.The primary end point was progression-free survival, on the basis of radiographic studies assessed by the local investigators, with central assessment by an unbiased radiology committee used in a supportive analysis. Secondary end points included overall survival, overall response rate, clinical benefit rate, period to deterioration of ECOG overall performance status, safety, and quality of life, by using the European Firm for Research and Treatment of Cancers quality-of-life core questionnaire and the breast cancer module . Blood levels of everolimus and plasma levels of exemestane had been assessed 4 weeks after randomization in a subgroup of 80 patients. Plasma degrees of estradiol had been assessed at screening or time 1 before starting trial therapy and at week 4 for the same patients.